{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:06:29Z","timestamp":1767827189403,"version":"3.49.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejpb.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T13:01:41Z","timestamp":1651755701000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The dose-duration effect on cutaneous pharmacokinetics of metronidazole from topical dermatological formulations in Yucatan mini-pigs"],"prefix":"10.1016","volume":"175","author":[{"given":"Benjamin A.","family":"Kuzma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharareh","family":"Senemar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tannaz","family":"Ramezanli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam G.","family":"Raney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Stagni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejpb.2022.05.001_b0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1773-2247(14)50044-5","article-title":"Applications of dermal microdialysis: a review","volume":"24","author":"Shukla","year":"2014","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/srt.12071","article-title":"Clinical applicability of dOFM devices for dermal sampling","volume":"19","author":"Bodenlenz","year":"2013","journal-title":"Skin Res Technol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0015","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s40262-016-0442-z","article-title":"Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence","volume":"56","author":"Bodenlenz","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2022.05.001_b0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000320151","article-title":"Are marketed topical metronidazole creams bioequivalent? Evaluation by in vivo microdialysis sampling and tape stripping methodology","volume":"24","author":"Garcia Ortiz","year":"2011","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejps.2008.09.002","article-title":"Application of dermal microdialysis for the evaluation of bioequivalence of a ketoprofen topical gel","volume":"36","author":"Tettey-Amlalo","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.05.001_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105741","article-title":"Evaluation of local bioavailability of metronidazole from topical formulations using dermal microdialysis: Preliminary study in a Yucatan mini-pig model","volume":"159","author":"Kuzma","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.05.001_b0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000330489","article-title":"Application of dermal microdialysis for the determination of bioavailability of clobetasol propionate applied to the skin of human subjects","volume":"25","author":"Au","year":"2012","journal-title":"Skin Pharmacol. Physiol."},{"issue":"Suppl 1","key":"10.1016\/j.ejpb.2022.05.001_b0040","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0169-409X(02)00117-5","article-title":"Assessment of cutaneous drug delivery using microdialysis","volume":"54","author":"Kreilgaard","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.05.001_b0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.jid.5700495","article-title":"Bioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic method","volume":"127","author":"Benfeldt","year":"2007","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11095-020-02920-x","article-title":"Variability of Skin Pharmacokinetic Data: Insights from a Topical Bioequivalence Study Using Dermal Open Flow Microperfusion","volume":"37","author":"Bodenlenz","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.05.001_b0055","unstructured":"F. Sinner, In Vivo Dermal Open Flow Microperfusion: A Novel Approach to Evaluating Topical Bioavailability and Bioequivalence, in, Joanneum Research Health, 2017."},{"key":"10.1016\/j.ejpb.2022.05.001_b0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000029928","article-title":"The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations\u2013an overview","volume":"13","author":"Simon","year":"2000","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0300985811402846","article-title":"Swine as models in biomedical research and toxicology testing","volume":"49","author":"Swindle","year":"2012","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0070","first-page":"391","article-title":"Comparison of two porcine (Sus scrofa domestica) skin models for in vivo near-infrared laser exposure","volume":"50","author":"Eggleston","year":"2000","journal-title":"Comp. Med."},{"key":"10.1016\/j.ejpb.2022.05.001_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-019-2741-1","article-title":"Effect of controlled heat application on topical diclofenac formulations evaluated by in vitro permeation tests (IVPT) using porcine and human skin","volume":"37","author":"Thomas","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.05.001_b0080","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1021\/mp400227e","article-title":"Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation","volume":"10","author":"Milewski","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2022.05.001_b0085","author":"BioResources","year":"2015","journal-title":"Miniature Swine Book of Normals"},{"key":"10.1016\/j.ejpb.2022.05.001_b0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.0022-202X.2003.22110.x","article-title":"Variations of hair follicle size and distribution in different body sites","volume":"122","author":"Otberg","year":"2004","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0095","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.addr.2012.04.003","article-title":"Modeling the human skin barrier\u2013towards a better understanding of dermal absorption","volume":"65","author":"Jepps","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.05.001_b0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.addr.2012.04.009","article-title":"Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes","volume":"65","author":"Anissimov","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.05.001_b0105","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0169-409X(03)00118-2","article-title":"Mechanistic and empirical modeling of skin permeation of drugs","volume":"55","author":"Yamashita","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.05.001_b0110","doi-asserted-by":"crossref","unstructured":"K.A. Walters, M.S. Roberts, The structure and function of skin, in: Dermatological and transdermal formulations, CRC Press, 2002, pp. 19\u201358.","DOI":"10.1201\/9780824743239-4"},{"key":"10.1016\/j.ejpb.2022.05.001_b0115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/jps.2600600511","article-title":"Pharmacokinetics of ampicillin trihydrate, sodium ampicillin, and sodium dicloxacillin following intramuscular injection","volume":"60","author":"Dolusio","year":"1971","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.05.001_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-3-1","article-title":"The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption","volume":"3","author":"Levitt","year":"2003","journal-title":"BMC Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0125","first-page":"90","article-title":"Pharmacokinetics tricks and traps: flip-flop models","volume":"1","author":"Boxenbaum","year":"1998","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.05.001_b0130","first-page":"89","article-title":"Skin transport","volume":"119","author":"Roberts","year":"2002","journal-title":"Drugs Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.05.001_b0135","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/0091270006297748","article-title":"Pharmacokinetics of a rivastigmine transdermal patch formulation in healthy volunteers: relative effects of body site application","volume":"47","author":"Lefevre","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0140","unstructured":"B.A. Kuzma, S. Senemar, R. DePinto, G. Stagni, LC-MS\/MS Method for the Quantification of Metronidazole in skin dialysate, in: AAPS Annual Conference, Washington, D.C., 2018."},{"key":"10.1016\/j.ejpb.2022.05.001_b0145","unstructured":"B.A. Kuzma, Investigation of Percutaneous Drug Pharmacokinetics in Yucatan Mini-Pig Utilizing Microdialysis: Development of an In Vitro-In-Vivo Relationship with Metronidazole Topical Dermatological Drug Products, in: Pharmaceutical Sciences, Long Island University, Brooklyn, NY, 2020."},{"key":"10.1016\/j.ejpb.2022.05.001_b0150","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s11095-006-9206-z","article-title":"AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives","volume":"24","author":"Chaurasia","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.05.001_b0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-409X(00)00114-9","article-title":"Analytical considerations for microdialysis sampling","volume":"45","author":"Davies","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.05.001_b0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-0270(91)90114-F","article-title":"The internal reference technique in microdialysis: a practical approach to monitoring dialysis efficiency and to calculating tissue concentration from dialysate samples","volume":"40","author":"Scheller","year":"1991","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejpb.2022.05.001_b0165","series-title":"Microdialysis in drug development","author":"M\u00fcller","year":"2013"},{"key":"10.1016\/j.ejpb.2022.05.001_b0170","unstructured":"FDA, Statistical Approaches to Establishing Bioequivalence, in: C.f.D.E.a.R. (CDER) (Ed.), 2001."},{"key":"10.1016\/j.ejpb.2022.05.001_b0175","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pst.210","article-title":"A note on the power of Fisher's least significant difference procedure","volume":"5","author":"Meier","year":"2006","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.ejpb.2022.05.001_b0180","unstructured":"S.N. Murthy, Characterizing the Critical Quality Attributes and In Vitro Bioavailability of Acyclovir and Metronidazole Topical Products, in: Topical Dermatological Generic Drug Products: Overcoming Barriers to Development and Improving Patient Access, White Oak, MD, 2017."},{"key":"10.1016\/j.ejpb.2022.05.001_b0185","unstructured":"Q. Zhang, P. Ghosh, S.G. Raney, H. D.C., H.E. Hassan, A.L. Stinchcomb, Characterization of the Cutaneous Pharmacokinetics of Three Metronidazole Topical Drug Products Evaluated by an In Vitro Permeation Test (IVPT) with Excised Human Skin, in: AAPS Annual Meeting, San Diego, 2017."},{"key":"10.1016\/j.ejpb.2022.05.001_b0190","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2340\/00015555-0562","article-title":"Impact of adult atopic dermatitis on topical drug penetration: assessment by cutaneous microdialysis and tape stripping","volume":"89","author":"Garcia Ortiz","year":"2009","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0536.2008.01348.x","article-title":"The effect of irritant dermatitis on cutaneous bioavailability of a metronidazole formulation, investigated by microdialysis and dermatopharmacokinetic method","volume":"59","author":"Ortiz","year":"2008","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ejpb.2022.05.001_b0200","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1007\/s11095-016-1960-y","article-title":"Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution","volume":"33","author":"Bodenlenz","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.05.001_b0205","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11095-020-02962-1","article-title":"Evaluating Dermal Pharmacokinetics and Pharmacodymanic Effect of Soft Topical PDE4 Inhibitors: Open Flow Microperfusion and Skin Biopsies","volume":"37","author":"Eirefelt","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.05.001_b0210","doi-asserted-by":"crossref","unstructured":"D. Cooper, Y. Ye, L. Rolf, N. Zuhdi, The pig as potential organ donor for man, in: Xenotransplantation, Springer, 1991, pp. 481\u2013500.","DOI":"10.1007\/978-3-642-97323-9_30"},{"key":"10.1016\/j.ejpb.2022.05.001_b0215","series-title":"The minipig in biomedical research","author":"McAnulty","year":"2012"},{"key":"10.1016\/j.ejpb.2022.05.001_b0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-2427(94)90135-X","article-title":"The pig as a potential xenograft donor","volume":"43","author":"Sachs","year":"1994","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0225","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/sur.2019.273","article-title":"Lung Collapse during Mini-Thoracotomy Reduces Penetration of Cefuroxime to the Tissue: Interstitial Microdialysis Study in Animal Models","volume":"22","author":"Dergel","year":"2021","journal-title":"Surg. Infect. (Larchmt)"},{"key":"10.1016\/j.ejpb.2022.05.001_b0230","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s11095-011-0444-3","article-title":"Assessment of topical bioequivalence using dermal microdialysis and tape stripping methods","volume":"28","author":"Incecayir","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2022.05.001_b0235","first-page":"57","article-title":"In vitro drug release studies of metronidazole topical formulations through cellulose membrane, East and Central African","volume":"15","author":"Maru","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.05.001_b0240","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/10837450.2013.763265","article-title":"In vitro and in vivo evaluation of three metronidazole topical products","volume":"19","author":"Miron","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0245","first-page":"197","article-title":"Differential penetration of skin by topical metronidazole formulations","volume":"15","author":"Wagner","year":"1998","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejpb.2022.05.001_b0250","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jps.20829","article-title":"Effect of propylene glycol on ibuprofen absorption into human skin in vivo","volume":"97","author":"Herkenne","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.05.001_b0255","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0378-5173(01)00673-1","article-title":"Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers","volume":"221","author":"Raghavan","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.05.001_b0260","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000159265","article-title":"Effect of penetration modifiers on the dermal and transdermal delivery of drugs and cosmetic active ingredients","volume":"21","author":"Otto","year":"2008","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0265","series-title":"Topical Drug Bioavailability, Bioequivalence, and Penetration","first-page":"369","author":"Flynn","year":"1993"},{"key":"10.1016\/j.ejpb.2022.05.001_b0270","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02849891","article-title":"Percutaneous absorption kinetics of topical metronidazole formulations in vitro in the human cadaver skin model","volume":"24","author":"Elewski","year":"2007","journal-title":"Adv Ther"},{"key":"10.1016\/j.ejpb.2022.05.001_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2019.06.002","article-title":"Skin metabolism phase I and phase II enzymes in native and reconstructed human skin: a short review","author":"Kazem","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.ejpb.2022.05.001_b0280","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0378-5173(86)90179-1","article-title":"In vitro evaluation of dermal prodrug delivery\u2014transport and bioconversion of a series of aliphatic esters of metronidazole","volume":"32","author":"Johansen","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.05.001_b0285","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1124\/dmd.113.052548","article-title":"The role of human cytochrome P450 enzymes in the formation of 2-hydroxymetronidazole: CYP2A6 is the high affinity (low Km) catalyst","volume":"41","author":"Pearce","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2022.05.001_b0290","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00204-018-2232-x","article-title":"Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models","volume":"92","author":"Oesch","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0295","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejps.2003.11.004","article-title":"Differentiated in vivo skin penetration of salicylic compounds in hairless rats measured by cutaneous microdialysis","volume":"21","author":"Simonsen","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.05.001_b0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000330491","article-title":"Probe depth matters in dermal microdialysis sampling of benzoic acid after topical application: an ex vivo study in human skin","volume":"25","author":"Holmgaard","year":"2012","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0305","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000515113","article-title":"Comparison of membrane depth determination techniques for active ingredient skin penetration studies using microdialysis","volume":"34","author":"Lubda","year":"2021","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.ejpb.2022.05.001_b0310","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0168-3659(99)00214-X","article-title":"Intradermal microdialysis: kinetics of iontophoretically delivered propranolol in forearm dermis","volume":"63","author":"Stagni","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2022.05.001_b0315","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1016\/j.xphs.2021.06.008","article-title":"Evaluation of Benzylpenicillin as an Internal Standard for Measurement of Piperacillin Bone Concentrations Via Microdialysis","volume":"110","author":"Knudsen","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"13","key":"10.1016\/j.ejpb.2022.05.001_b0320","doi-asserted-by":"crossref","first-page":"PL73","DOI":"10.1016\/0024-3205(91)90082-M","article-title":"The use of an \u201cinternal standard\u201d for control of the recovery in microdialysis","volume":"49","author":"Larsson","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2022.05.001_b0325","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3356","article-title":"The Skin Reservoir Model: A Tool for Evaluating Microdialysis Sampling of Large Biomarkers from Human Skin","volume":"100","author":"Baumann","year":"2020","journal-title":"Acta Dermato-Venereologica"},{"key":"10.1016\/j.ejpb.2022.05.001_b0330","doi-asserted-by":"crossref","first-page":"643","DOI":"10.4155\/tde.11.19","article-title":"Flip-flop pharmacokinetics\u2013delivering a reversal of disposition: challenges and opportunities during drug development","volume":"2","author":"Yanez","year":"2011","journal-title":"Ther Deliv"},{"issue":"3","key":"10.1016\/j.ejpb.2022.05.001_b0335","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0168-3659(85)90015-X","article-title":"The prediction of plasma levels of drugs following transdermal application","volume":"1","author":"Guy","year":"1985","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2022.05.001_b0340","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ijpharm.2013.05.029","article-title":"A novel electronic skin patch for delivery and pharmacokinetic evaluation of donepezil following transdermal iontophoresis","volume":"453","author":"Saluja","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.05.001_b0345","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2885.2004.00600.x","article-title":"Plasma terminal half-life","volume":"27","author":"Toutain","year":"2004","journal-title":"J. Vet. Pharmacol. Ther."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:46:47Z","timestamp":1760546807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":69,"alternative-id":["S0939641122000893"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.05.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dose-duration effect on cutaneous pharmacokinetics of metronidazole from topical dermatological formulations in Yucatan mini-pigs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}